Good binocular results in children with early-onset exotropia

Article

The surgical outcomes for children treated for constant early-onset exotropia demonstrated good binocular results, claims a study in the journal Eye.

The surgical outcomes for children treated for constant early-onset exotropia demonstrated good binocular results, claims a study in the journal Eye.

A research team led by Dr S. Y. Suh, Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea, examined the medical records of 45 exotropia patients with a reported onset before one year of age. All patients were operated on between 2008 and 2011 and clinical characteristics and surgical outcomes were analysed retrospectively.

Patients were divided into either a constant exotropia group (XT) or and intermittent group (X(T)). The team compared clinical features and surgical results of exotropia between the two groups. The mean age at surgery was 4.5±2.4 years and the mean postoperative follow-up period was 17.3 months.

Of the total patients reviewed, 67% demonstrated an alignment of less than ±10 prism diopters (PD) at the final visit. In all 34 testable patients, gross stereopsis was achieved and bifixation was developed in 10 patients. There were no significant differences between the groups with regards to surgical success rates and binocularities.

Both motor and sensory surgical outcomes were not poor in early-onset exotropia patients, even in those with constant deviation.

The abstract can be read here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.